CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-06 | Smith Cynthia Director | Grant or award | +30,000 | 95,233 | ||
| 2023-06-06 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2023-06-06 | GILMAN STEVEN C Director | Grant or award | +30,000 | 87,130 | ||
| 2023-06-06 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +45,000 | 45,000 | ||
| 2023-05-25 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −63,186 | $1.22 | $77K | 524,344 |
| 2023-05-25 | Dahan Michel SVP, Chief Operating Officer | Sale | −95,478 | $1.22 | $117K | 574,037 |
| 2023-05-24 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award | +200,000 | 587,530 | ||
| 2023-05-24 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award · Employee Stock Option (Right to buy) | +200,000 | 200,000 | ||
| 2023-05-24 | Dahan Michel SVP, Chief Operating Officer | Grant or award | +200,000 | 669,515 | ||
| 2023-05-24 | Dahan Michel SVP, Chief Operating Officer | Grant or award · Employee Stock Option (Right to buy) | +200,000 | 200,000 | ||
| 2023-05-16 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −63,567 | $1.07 | $68K | 530,487 |
| 2023-05-16 | Spellman David A SVP, CFO and Treasurer | Sale | −63,567 | $1.07 | $68K | 446,483 |
| 2023-05-12 | Hadas Nicole R. SVP, Chief Legal Officer | Grant or award | +100,000 | 387,530 | ||
| 2023-05-12 | Dahan Michel SVP, Chief Operating Officer | Grant or award | +200,000 | 469,515 | ||
| 2023-03-01 | Butler John P. CEO and President | Sale | −38,259 | $0.88 | $34K | 1,622,481 |
| 2023-03-01 | Butler John P. CEO and President | Sale | −47,239 | $0.88 | $41K | 1,575,242 |
| 2023-03-01 | Butler John P. CEO and President | Sale | −6,370 | $0.88 | $6K | 1,568,872 |
| 2023-03-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −5,333 | $0.88 | $5K | 295,231 |
| 2023-03-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −6,613 | $0.88 | $6K | 288,618 |
| 2023-03-01 | Hadas Nicole R. SVP, Chief Legal Officer | Sale | −1,088 | $0.88 | $955 | 287,530 |
Page 8 of 21 · 405 trades